Evidence map›Paper›PMID 32203062›Full record

ArticleMucosal immunology2020

Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils.

Kaori L Fonseca, Ana Raquel Maceiras, Rita Matos, Luisa Simoes-Costa, Jeremy Sousa, Baltazar Cá, Leandro Barros, Ana Isabel Fernandes, Stefan Mereiter, Ricardo Reis and 14 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02715271 (Study of TB Lesions Obtained in Surgery), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02715271 completednot on this map

Study of TB Lesions Obtained in Surgery: in Search of Best Biomarkers Correlating With TB Pathology, Clinical Features, MDR Cases and Prognostic

Typeobservational_patient_registrySponsorFundació Institut Germans Trias i PujolRan2016 to 2024Enrolled192ConditionsTuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary, Tuberculosis, Multidrug-ResistantArmstherapeutical surgery for TB
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Infection with hypervirulentFrontiers in immunology · 2023
    Article
  15. Article
  16. Review
  17. Microorganisms · 2021
    Article
  18. Adhesion ofFrontiers in molecular biosciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 3 countries.

Kaori L Fonseca *i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.ORCID http://orcid.org/0000-0002-7048-9740
Ana Raquel Maceiras *i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Rita Matosi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Luisa Simoes-Costai3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Jeremy Sousai3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Baltazar Cái3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Leandro Barrosi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ana Isabel Fernandesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Stefan Mereiteri3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ricardo ReisCDP-Centro de Diagnóstico Pneumológico do Porto, Porto, Portugal.
Joana Gomesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Gustavo TapiaUAB-Pathology Department, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Paula Rodríguez-MartínezUAB-Pathology Department, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Montse Martín-CéspedesUAB-Pathology Department, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Sergo VashakidzeNational Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.
Shota GogishviliNational Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.
Keti NikolaishviliNational Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.
Rui Appelbergi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Fátima Gärtneri3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Pedro N S Rodriguesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Cristina VilaplanaUAB-Experimental Tuberculosis Unit. Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias. Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain.
Celso A Reisi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Ana Magalhãesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. amagalhaes@ipatimup.up.pt.
Margarida Saraivai3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. margarida.saraiva@ibmc.up.pt.
Universidade do Porto · PTUniversitat Autònoma de Barcelona · ESNational Center for Tuberculosis and Lung Disease · GEIPO Porto · PT

Funding

Structural Basis of Immune Recognition of Glycosylated AntigensU54GM062116 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI PAULSON, JAMES C · 2001 to 2010
$80.3M
Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
FIC NIH HHS D43 TW007124NIGMS NIH HHS U54 GM062116
6 · The paper itself

Abstract

Modulation of immunity and disease by glycans is increasingly recognized. However, how host glycosylation shapes and is shaped by tuberculosis remains poorly understood. We show that deficiency in the glucosaminyl (N-acetyl) transferase 1 (Gcnt1), a key enzyme for core-2 O-glycans biosynthesis, drives susceptibility to Mycobacterium tuberculosis infection. The increased susceptibility of Gcnt1 deficient mice was characterized by extensive lung immune pathology, mechanistically related to neutrophils. Uninfected Gcnt1 deficient mice presented bone marrow, blood and lung neutrophilia, which further increased with infection. Blood neutrophilia required Gcnt1 deficiency in the hematopoietic compartment, relating with enhanced granulopoiesis, but normal cellular egress from the bone marrow. Interestingly, for the blood neutrophilia to translate into susceptibility to M. tuberculosis infection, Gnct1 deficiency in the stroma was also necessary. Complete Gcnt1 deficiency associated with increased lung expression of the neutrophil chemoattractant CXCL2. Lastly, we demonstrate that the transcript levels of various glycosyltransferase-encoding genes were altered in whole blood of active tuberculosis patients and that sialyl Lewis x, a glycan widely present in human neutrophils, was detected in the lung of tuberculosis patients. Our findings reveal a previously unappreciated link between Gcnt1, neutrophilia and susceptibility to M. tuberculosis infection, uncovering new players balancing the immune response in tuberculosis.

Indexed as

Genetic Predisposition to DiseaseMycobacterium tuberculosisAnimalsBacterial LoadBiomarkersDisease Models, AnimalEnzyme ActivationGene Expression RegulationGlycosylationHost-Pathogen InteractionsMiceMice, KnockoutN-AcetylglucosaminyltransferasesNeutrophilsSurvival RateTuberculosisbeta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferaseBiomarkersN-Acetylglucosaminyltransferases

Identifiers

PMID32203062
PMCPMC7434595
OpenAlexW3011011257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.